PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia | Science Advances
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma | Cancer Cell International | Full Text
Anti-CD58 Antikörper (A11863) | Antibodies.com
CD58 Antibody (HCD58) | SCBT - Santa Cruz Biotechnology
BV605 Mouse Anti-Human CD58
Biomarker predicts poor response to CAR-T, points way to personalized, gene-edited therapy
Full article: Association of CD58 Polymorphisms and its Protein Expression with the Development and Prognosis of Autoimmune Thyroid Diseases
Anti-CD2 ADC - Creative Biolabs
![Recombinant PE Anti-CD58 antibody [EPR24012-147] (ab306539) | Abcam](https://www.abcam.com/ps/products/306/ab306539/Images/ab306539-1-anti-cd58-antibody-epr24012-147-pe-flow-cytometry-human.jpg "Recombinant PE Anti-CD58 antibody [EPR24012-147] (ab306539) | Abcam")
Recombinant PE Anti-CD58 antibody [EPR24012-147] (ab306539) | Abcam
Frontiers | CD58 Immunobiology at a Glance
A Good CD58 Antibody from Thermo | Biocompare Antibody Review
High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer | Anticancer Research
Molecules | Free Full-Text | Virtual Screening and Binding Analysis of Potential CD58 Inhibitors in Colorectal Cancer (CRC)
The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low-grade gliomas and potential therapeutic approaches,Immunity, Inflammation and Disease - X-MOL
CD58 Antikörper
CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer | Oncogene
CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway | Journal of Translational Medicine | Full Text
Exosome Engineering
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity - ScienceDirect
CD58 (LFA-3) Antibody, anti-human | Hybridomas | MACS Antibodies | Products and services | Schweiz
The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches - Wu - 2023 - Immunity, Inflammation and Disease - Wiley Online Library
Model of CD2–CD58 avidity regulation. We propose a comprehensive model... | Download Scientific Diagram
CD58 Antikörper
CD58 Antikörper
Known mechanisms of immune evasion and distinct role of CD58 a,... | Download Scientific Diagram
